Mohsen Moghadami

Mohsen Moghadami

Auto-generated profile, based on publicly available information

Mohsen Moghadami

Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2021 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
KRKeivan Ranjbar
Keivan Ranjbar
MMMohsen Moghadami
Mohsen Moghadami
AMAlireza Mirahmadizadeh
Alireza Mirahmadizadeh
MFMohammad Javad Fallahi
Mohammad Javad Fallahi
VKVahid Khaloo
Vahid Khaloo
MSMohammad Hasan Gholampoor Saadi
Mohammad Hasan Gholampoor Saadi
Background: Although almost a year has passed since the Coronavirus disease 2019 (COVID-19) outbreak and promising reports of vaccines have been presented, we still have a long way until these measures are available for all. Furthermore, the most appropriate corticosteroid and dose in the treatment of COVID-19 have remained uncertain. We conducted a study to assess the effectiveness of methylprednisolone treatment versus dexamethasone for hospitalized COVID-19 patients. Methods: In this prospective triple-blinded randomized controlled trial, we enrolled 86 hospitalized COVID-19 patients from August to November 2020, in Shiraz, Iran. The patients were randomly allocated into two groups to receive either methylprednisolone (2 mg/kg/day; intervention group) or dexamethasone (6 mg/day; control group). Data were assessed based on a 9-point WHO ordinal scale extending from uninfected (point 0) to death (point 8). Results: There were no significant differences between the groups on admission. However, the intervention group demonstrated significantly better clinical status compared to the control group at day 5 (4.02 vs. 5.21, p = 0.002) and day 10 (2.90 vs. 4.71, p = 0.001) of admission. There was also a significant difference in the overall mean score between the intervention group and the control group, (3.909 vs. 4.873 respectively, p = 0.004). The mean length of hospital stay was 7.43 ± 3.64 and 10.52 ± 5.47 days in the intervention and control groups, respectively (p = 0.015). The need for a ventilator was significantly lower in the intervention group than in the control group (18.2% vs 38.1% p = 0.040). Conclusion: In hospitalized hypoxic COVID-19 patients, methylprednisolone demonstrated better results compared to dexamethasone. Trial registration: The trial was registered with IRCT.IR (08/04/2020-No. IRCT20200204046369N1).

1 January 2014 in International Journal of Health Policy and Management
Verified
Journal Article
Open access
PDF file
EKElham Kavosi
Elham Kavosi
ZRZahra Hassanzadeh Rostami
Zahra Hassanzadeh Rostami
ZKZahra Kavosi
Zahra Kavosi
ANAliasghar Nasihatkon
Aliasghar Nasihatkon
MMMohsen Moghadami
Mohsen Moghadami
MHMohammad Reza Heydari
Mohammad Reza Heydari
Background Childhood malnutrition as a major public health problem among children in developing countries can affect physical and intellectual growth and is also considered as a main cause of child morbidity and mortality. The objective of this study was to estimate the prevalence of under-nutrition and identify determinants of malnutrition among children under 6 years of age in Fars province, Iran. Methods This survey was conducted by house to house visit through multi-stage sampling in 30 cities of Fars province, during December 2012 to January 2013. A total of 15408 children, aged 0–6 years old, were studied for nutritional assessment in terms of underweight, stunting, and wasting. Also, socio-demographic measures were obtained from structured questionnaire. Backward stepwise logistic regression was used to relate underlying factors to the odds of under-nutrition indices. Results The rates of stunting, underweight, and wasting were 9.53, 9.66, and 8.19%, respectively. Male children were more stunted compared to females (OR= 1.41, CI: 1.26–1.58). Also, stunting was significantly associated with lower family income (OR= 3.21, CI: 1.17–8.85) and lower maternal education (OR= 0.80, CI: 0.64–0.98). Living in urban areas, and poor water supply were identified as significant risk factors of all three types of childhood under-nutrition. Moreover, Khamse and Arab ethnic groups were more vulnerable to under-nutrition. There was a suggestion that non-access to health services were associated with wasting (OR= 1.87, CI: 1.39–2.52) and also large family size was related to underweight (OR= 1.35, CI: 1.10–1.65). Conclusion The prevalence of under-nutrition in the study population was categorized in low levels. However, planning the public preventive strategies can help to control childhood under-nutrition according to underlying factors of malnutrition in the study population including gender, settlement area, family size, ethnicity, family income, maternal education, health services, and also safe water supply.

18 June 2020 in BMC Infectious Diseases
Verified
Journal Article
Open access
RSReza Shahriarirad
Reza Shahriarirad
ZKZohre Khodamoradi
Zohre Khodamoradi
AEAmirhossein Erfani
Amirhossein Erfani
HHHamidreza Hosseinpour
Hamidreza Hosseinpour
KRKeivan Ranjbar
Keivan Ranjbar
MMMohsen Moghadami
Mohsen Moghadami
Background: In March 2020, the WHO declared the novel coronavirus (COVID-19) outbreak a global pandemic. Although the number of infected cases is increasing, information about its clinical characteristics in the Middle East, especially in Iran, a country which is considered to be one of the most important focal points of the disease in the world, is lacking. To date, there is no available literature on the clinical data on COVID-19 patients in Iran. Methods: In this multicenter retrospective study, 113 hospitalized confirmed cases of COVID-19 admitted to university affiliated hospitals in Shiraz, Iran from February 20 to March 20 were entered in the study. Results: The mean age was 53.75 years and 71 (62.8%) were males. The most common symptoms at onset were fatigue (75: 66.4%), cough (73: 64.6%), and fever (67: 59.3%). Laboratory data revealed significant correlation between lymphocyte count (P value = 0.003), partial thromboplastin time (P value = 0.000), international normalized ratio (P value = 0.000) with the severity of the disease. The most common abnormality in chest CT scans was ground-glass opacity (77: 93.9%), followed by consolidation (48: 58.5%). Our results revealed an overall 8% (9 out of 113 cases) mortality rate among patients, in which the majority was among patients admitted to the ICU (5: 55.6%). Conclusion: Evaluating the clinical data of COVID-19 patients and finding the source of infection and studying the behavior of the disease is crucial for understanding the pandemic.

1 January 2021 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
SHSeyyed Alireza Hashemi
Seyyed Alireza Hashemi
NBNader Ghaleh Golab Behbahan
Nader Ghaleh Golab Behbahan
SBSonia Bahrani
Sonia Bahrani
SMSeyyed Mojtaba Mousavi
Seyyed Mojtaba Mousavi
Ahmad GholamiAhmad Gholami
Ahmad Gholami
NONavid Omidifar
Navid Omidifar

10 February 2007 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
SSSepideh Sefidbakht
Sepideh Sefidbakht
ARA. R. Rasekhi
A. R. Rasekhi
KKK. Kamali
K. Kamali
AHA. Borhani Haghighi
A. Borhani Haghighi
ASA. Salooti
A. Salooti
SNSeyed Ali Nabavizadeh
Seyed Ali Nabavizadeh

1 April 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
ZKzohre khodamoradi
zohre khodamoradi
MMMohsen Moghadami
Mohsen Moghadami
MLMehrzad Lotfi
Mehrzad Lotfi
Background: In late December 2019, a viral pneumonia known as coronavirus disease 2019 (COVID-19) originated from China and spread very rapidly in the world. Since then, COVID-19 has become a global concern and health problem. Methods: We present four patients in this study, selected from among patients who presented with pneumonia symptoms and were suspicious for COVID-19. They were referred to the intended centers for COVID-19 diagnosis and management of Shiraz University of Medical Sciences in southern Iran. Two nasopharyngeal and oropharyngeal throat swab samples were collected from each patient and tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using real-time reverse-transcriptase– polymerase-chain-reaction (RT-PCR). The samples were also tested for influenza viruses and the complete respiratory panel. Results: In the present report, four patients were diagnosed in the starting days of COVID-19 disease in our center in southern Iran with co-infection of SARS-CoV-2 and influenza A virus. Conclusion: This co-infection of COVID-19 and influenza A highlights the importance of considering SARS-CoV-2 PCR assay regardless of other positive findings for other pathogens in the primary test during the epidemic.